Zhejiang Taimei Med Tech Co (2576) fair value: what the stock is really worth
As of Nov 13, 2026: fair value (intrinsic value) of Zhejiang Taimei Med Tech Co stock HK$3.77, price HK$4.52, that is 16.5% below the price, quality 55 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Zhejiang Taimei Med Tech Co
2576 · HKExpensive (fair value 17% below the price) and price moving sideways, but solid company: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.
How to read this chart
25‑month range HK$3.10 – HK$9.20 · fair‑value band HK$2.83 – HK$4.72 · the HK$4.52 price screens above the HK$3.77 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.
Every Wednesday you see whether Zhejiang Taimei Med Tech Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Zhejiang Taimei Medical Technology Co., Ltd. provides digital solutions for life sciences research, development, and commercialization in Mainland China and internationally.
Show moreShow less
The company offers Wiz.AI, an AI platform for clinical trials; TrialOS pharmaceutical R&D collaboration platform; PharmaOS, a pharmaceutical digital marketing platform; and the enterprise-medical academic interaction platform.
It also provides pharmaceutical R&D solutions comprising eCollect, eBalance, eCooperate, eArchives, eImage medical imaging evaluation system, eSMS site management system, Paylite financial management system, and eCollege training management system; TrialPartner digital SMO services, IRC independent review center solutions, and eSAE clinical trial safety information management system; eSitePro clinical trial management platform, eTrialPro research ward management system, GCP-X intelligent clinical trial platform, IIT-EDC research data collection system, eScreening subject information management system, eMonitoring intelligent remote monitoring system, and IDS investigational drug services; and IDCT intelligent decentralized clinical trial.
In addition, the company offers eSafety pharmacovigilance compliance management system; eSAE clinical trial safety information management system; ONECEM omni-channel marketing platform, such as ONECEM-SFE sales operation system, ONECEM-SCRM intelligent marketing system, and ONECEM-event+engagement system; and ONEInsight marketing data platform, including boundless corporate medical interaction platform.
Further, it provides research and development support; technical, clinical operation, data management, statistical analysis, and management services; independent image evaluation services; and pharmaceutical marketing and institution digitalization solutions.
The company was formerly known as Jiaxing Taimei Medical Technology Co., Ltd. Zhejiang Taimei Medical Technology Co., Ltd.was founded in 2013 and is headquartered in Jiaxing, China.
Stock analysis
Zhejiang Taimei Med Tech Co (2576) currently trades at HK$4.52, while our estimate is HK$3.77, 17% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: HK$2.83 (bear) to HK$4.72 (bull), the price of HK$4.52 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 55/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Zhejiang Taimei Med Tech Co reported revenue of 499M CNY in FY2025 versus 466M CNY in FY2021, a compound +1.7%/yr. Reported net income was −41.7M CNY in FY2025.
Key figures
Market cap HK$2.5B (≈ $324M) Small · P/S ratio 4.37 · Net margin −8.4% · Return on equity −5.9% · Return on assets (EBIT) −19.9% (5-year average) · Operating margin −12.9% · Revenue (TTM) 532M CNY · Revenue growth (YoY) +8.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 11 out of 100 (low confidence).
What moves the price
The share trades about 40% below its 52-week high and 21% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −17%, 2576 screens cheaper than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
2576 screens overvalued: fair value 17% below the price. Compare with Veeva Systems Inc →
Compare Zhejiang Taimei Med Tech Co with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 142 stocks
Valuation Multiplesvs Health Information Services median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on equity by industry
- Quality Score by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Hong Kong Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Veeva Systems Inc VEEV | $301.53 | $332.66 | +10% | vs 2576 |
| Doximity, Inc DOCS | $33.34 | $36.54 | +10% | vs 2576 |
| HealthEquity, Inc HQY | $103.46 | $113.36 | +10% | vs 2576 |
| Waystar Holding WAY | $27.99 | $29.10 | +4% | vs 2576 |
| Tempus AI, Inc TEM | $71.60 | $52.58 | −27% | vs 2576 |
| HeartFlow, Inc HTFL | $48.46 | $30.56 | −37% | vs 2576 |
| Hinge Health, Inc HNGE | $115.39 | $51.25 | −56% | vs 2576 |
| Pro Medicus Limited PME | A$202.57 | A$85.12 | −58% | vs 2576 |
| BrightSpring Health Services, Inc BTSG | $71.21 | $25.72 | −64% | vs 2576 |
| XtalPi Holdings 2228 | HK$5.87 | HK$1.53 | −74% | vs 2576 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Zhejiang Taimei Med Tech Co (2576) overvalued or undervalued?
What is the fair value of 2576?
What is the quality score of 2576?
What is the price target for Zhejiang Taimei Med Tech Co (2576)?
What is the Zhejiang Taimei Med Tech Co stock forecast for 2026?
What is the revenue of Zhejiang Taimei Med Tech Co (2576)?
What is the intrinsic value of Zhejiang Taimei Med Tech Co (2576)?
Is Zhejiang Taimei Med Tech Co stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 2576?
How much is Zhejiang Taimei Med Tech Co worth?
What do the bullish and bearish scenarios say about 2576?
How solid is the balance sheet of Zhejiang Taimei Med Tech Co (2576)?
How far is 2576 from its 52-week high?
Which stocks are comparable to Zhejiang Taimei Med Tech Co?
Is Zhejiang Taimei Med Tech Co stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Zhejiang Taimei Med Tech Co (2576)?
What should I pay attention to with Zhejiang Taimei Med Tech Co right now?
Key figures of Zhejiang Taimei Med Tech Co
How large is the market capitalisation of Zhejiang Taimei Med Tech Co (2576)?
What is the P/S ratio of Zhejiang Taimei Med Tech Co (2576)?
What is the net margin of Zhejiang Taimei Med Tech Co (2576)?
What is the return on equity of Zhejiang Taimei Med Tech Co (2576)?
What is the EBIT return on assets of Zhejiang Taimei Med Tech Co (2576)?
What is the operating margin of Zhejiang Taimei Med Tech Co (2576)?
How fast is revenue growing at Zhejiang Taimei Med Tech Co (2576)?
How much free cash flow does Zhejiang Taimei Med Tech Co (2576) generate?
How much net cash does Zhejiang Taimei Med Tech Co (2576) hold?
Watch Zhejiang Taimei Med Tech Co in the live analysis
One click puts Zhejiang Taimei Med Tech Co on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.